Immunoglobulin Market - Global Industry Analysis

Immunoglobulin Market

Immunoglobulin Market by Mode of Delivery (Subcutaneous and Intravenous), by Application (Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and Others), and by Product Type (IgA, IgD, IgG, IgE, and IgM): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 25-Jan-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3763 Status : Published

Global immunoglobulin market expected to generate around USD 16.6 billion by 2024, at a CAGR of around 7.6% between 2018 and 2024. Increasing geriatric population worldwide, steep rise in the cases of neurological disorders, and rising hemophilic patient numbers are likely to drive the global immunoglobulin market in the upcoming years.

Description

The report covers a forecast and an analysis of the immunoglobulin market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the immunoglobulin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunoglobulin market on a global and regional level.

In order to give the users of this report a comprehensive view of the immunoglobulin market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunoglobulin Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immunoglobulin market on a global and regional basis.

The study provides a decisive view of the immunoglobulin market by segmenting the market based on mode of delivery, application, product type, and region. By mode of delivery, the immunoglobulin market is segmented into subcutaneous and intravenous. Subcutaneous is further segmented into 16.5% concentration, 20% concentration, and others. Intravenous is further segmented into 5% concentration, 10% concentration, and others. The application segment includes Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and others. By product type, this market includes IgA, IgD, IgG, IgE, and IgM.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some market players of the global immunoglobulin market are ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Grifols S.A., LFB Biomedicaments S.A., Kedrion S.p.A., Sanquin Plasma Products B.V., and Octapharma AG, among others.

This report segments the global immunoglobulin market into:

Global Immunoglobulin Market: By Mode of Delivery

  • Subcutaneous
    • 16.5% Concentration
    • 20% Concentration
    • Others
  • Intravenous
    • 5% Concentration
    • 10% Concentration
    • Others

Global Immunoglobulin Market: By Application

  • Hypogammaglobulinemia
  • Immunodeficiency Disease
  • Multifocal Motor Neuropathy
  • Guillain-Barre Syndrome
  • Myasthenia Gravis
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Idiopathic Thrombocytopenic Purpura
  • Specific Antibody Deficiency
  • Inflammatory Myopathies
  • Others

Global Immunoglobulin Market: By Product Type

  • IgA
  • IgD
  • IgG
  • IgE
  • IgM

Global Immunoglobulin Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

Free Analysis

Immunoglobulins are glycoprotein molecules that are produced by white blood cells (plasma cells). Immunoglobulins, also referred to as antibodies, operate as a perilous portion of the immune response by precisely recognizing and attaching themselves to specific antigens, such as viruses or bacteria, and assisting in their annihilation. This antibody response is extremely complex and exceptionally specific. The amino acid configuration of antibodies differs, thereby permitting them to interact with numerous diverse antigens. The applications of immunoglobulin include disease diagnosis, disease therapy, and prenatal therapy. The numerous antibodies manufactured by plasma cells are categorized by isotype, where every single type varies in role and antigen responses chiefly due to assembly variability.

The growing incidences of autoimmune diseases, such as multiple sclerosis, primary humoral immunodeficiency, immune thrombocytopenia purpura (ITP), Kawasaki syndrome, and autoimmune hemolytic anemia, increasing geriatric population worldwide, steep rise in the cases of neurological disorders, and rising hemophilic patient numbers are likely to drive the global immunoglobulin market in the upcoming years. Technological advancements in purification and production methods along with the efforts taken by government and non-government organizations to create awareness regarding autoimmune diseases are anticipated to further fuel the immunoglobulin market over the estimated timeframe. Nonetheless, strict government guidelines related to immunoglobulin products and several side effects of immunoglobulin use might restrict the global immunoglobulin market on a global scale.

Global Immunoglobulin Market

By mode of delivery, the immunoglobulin market is segmented into subcutaneous and intravenous. Subcutaneous is further segmented into 16.5% concentration, 20% concentration, and others. Intravenous is further segmented into 5% concentration, 10% concentration, and others. The application segment includes Hypogammaglobulinemia, Immunodeficiency Disease, Multifocal Motor Neuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Inflammatory Myopathies, and others. By product type, this market includes IgA, IgD, IgG, IgE, and IgM.

By region, the North American immunoglobulin market is likely to lead over the forecast time period. This can be attributed to the presence of a high number of major players operating in the immunoglobulin market, the existence of big plasma manufacturing units, high acceptance of modern technologies in immunoglobulin, and the region’s well-established healthcare sector. Europe is anticipated to be the second largest immunoglobulin market in the future, owing to the growing geriatric population and increasing number of hemophilic patients. The maximum percentage of people aged 60 or above are in Europe. The Asia Pacific market is projected to propagate at a speedy rate over the forecast period, owing to the growing per capita healthcare expenditure, rapid advancement of healthcare infrastructure, and increased focus on research and development. The Latin American immunoglobulin market is likely to grow significantly over the estimated time period.

Some key players of the global immunoglobulin market include ADMA Biologics, Inc., Shire plc, CSL Behring LLC, China Biologic Products, Inc., Grifols S.A., LFB Biomedicaments S.A., Kedrion S.p.A., Sanquin Plasma Products B.V., and Octapharma AG, among others.?

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed